MoneyWorks4Me

Astal Laboratories - Quaterly Results

19 May 2025 Evaluate
The topline surged 91.54% to Rs. 234.67 millions for the March 2025 quarter as against Rs. 122.52 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 391.76% to Rs. 27.44  millions  from Rs. 5.58 millions in previous same quarter.OP of the company witnessed a marginal growth to 42.18 millions from 5.78 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 234.67 122.52 91.54 642.31 236.48 171.61 642.31 236.48 171.61
Other Income 0.35 0.00 0.00 1.25 0.13 861.54 1.25 0.13 861.54
PBIDT 42.18 5.78 629.76 129.02 11.28 1043.79 129.02 11.28 1043.79
Interest 2.66 0.00 0.00 7.01 0.11 6272.73 7.01 0.11 6272.73
PBDT 39.52 5.78 583.74 122.01 11.17 992.30 122.01 11.17 992.30
Depreciation 1.04 0.20 420.00 2.23 0.30 643.33 2.23 0.30 643.33
PBT 38.48 5.58 589.61 119.78 10.87 1001.93 119.78 10.87 1001.93
TAX 11.04 0.00 0.00 30.52 3.02 910.60 30.52 3.02 910.60
Deferred Tax -0.11 0.00 0.00 1.11 0.08 1287.50 1.11 0.08 1287.50
PAT 27.44 5.58 391.76 89.26 7.85 1037.07 89.26 7.85 1037.07
Equity 98.46 98.46 0.00 98.46 98.46 0.00 98.46 98.46 0.00
PBIDTM(%) 17.97 4.72 281.00 20.09 4.77 321.11 20.09 4.77 321.11
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..